Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

unknown120%

completed480%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss

NCT07280403

unknownnot_applicable

The Acute Effect of Low-carb Diet on the Plasma Fatty Acid Composition in Type 2 Diabetes

NCT05498688

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT07280403Not Applicable

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss

Completed

NCT05498688Not Applicable

The Acute Effect of Low-carb Diet on the Plasma Fatty Acid Composition in Type 2 Diabetes

Unknown

NCT03250234Not Applicable

Carbohydrate Availability and microRNA Expression

Completed

NCT04293003Not Applicable

Metabolic Effects of Morning 16/8 Fasting

Completed

NCT00726908Not Applicable

Intramuscular Lipid and Insulin Action:Ethnic Aspects

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5